Investigational nanomedicines in 2016: a review of nanotherapeutics currently undergoing clinical trials.

Published

Journal Article (Review)

Nanomedicine is a relatively new field that is rapidly evolving. Formulation of drugs on the nanoscale imparts many physical and biological advantages. Such advantages can in turn translate into improved therapeutic efficacy and reduced toxicity. While approximately 50 nanotherapeutics have already entered clinical practice, a greater number of drugs are undergoing clinical investigation for a variety of indications. This review aims to examine all the nanoformulations that are currently undergoing clinical investigation and their outlook for ultimate clinical translation. WIREs Nanomed Nanobiotechnol 2017, 9:e1416. doi: 10.1002/wnan.1416 For further resources related to this article, please visit the WIREs website.

Full Text

Duke Authors

Cited Authors

  • Caster, JM; Patel, AN; Zhang, T; Wang, A

Published Date

  • January 2017

Published In

Volume / Issue

  • 9 / 1

PubMed ID

  • 27312983

Pubmed Central ID

  • 27312983

Electronic International Standard Serial Number (EISSN)

  • 1939-0041

Digital Object Identifier (DOI)

  • 10.1002/wnan.1416

Language

  • eng

Conference Location

  • United States